ClinicalTrials.Veeva

Menu

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

Wyeth logo

Wyeth

Status and phase

Completed
Phase 3

Conditions

Depression

Treatments

Drug: Effexor XR

Study type

Interventional

Funder types

Industry

Identifiers

NCT00225485
0600B1-817

Details and patient eligibility

About

Phase III study evaluating Effexor XR in elderly patients with major depression.

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with major depression based on DSM-IV-TR
  • Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" of HAM-D at baseline

Exclusion criteria

  • Patients with schizophrenia or any other psychotic disorder
  • Patients with history or presence of bipolar disorder

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

37

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems